On January 29, 2026, Galderma announced the launch of “Wake Up to Restylane,” a global campaign showcasing Restylane’s ability to deliver personalized results and improve skin quality.
The launch, which was unveiled at the IMCAS World Congress 2026 in Paris, was designed to meet the rising demand for natural-looking results, helping people wake up looking refreshed and rested. Galderma also showcased new clinical data reinforcing Restylane’s efficacy across key facial areas, such as the chin, jawline, temples and decolletage.
“What’s compelling about ‘Wake Up to Restylane’ is its focus on beauty that’s ready when you are,” said Dr. Kuldeep Minocha, aesthetic physician at L’Art by Dr M. “Patients increasingly want treatments that fit seamlessly into their lives, and this campaign captures that shift perfectly. For practitioners, Restylane continues to set the benchmark for HA treatments and remains an indispensable tool in modern aesthetic practice thanks to its proven science, unmatched versatility and reliability and personalized, natural-looking results.”
The campaign captures the growing desire to look “subtly refreshed” without the effort, especially towards beauty-conscious consumers. Galderma’s Restylane hyaluronic acid treatment porfolio offers personalized treatments that deliver structural support and natural-looking results.
“Restylane has an iconic heritage as trusted, science-backed HA treatment, and ‘Wake Up to Restylane’ is an exciting evolution in how we connect the brand with evolving beauty aspirations,” said Gerry Muhle, head of global product strategy at Galderma. “We’re not just responding to change – we’re leading it – driving the category forward, including for those taking their first steps into aesthetics, while staying true to the authentic always-on beauty and personalization that define the brand.”
